PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Molecular tests provide more convenient, personalized monitoring of heart transplant recipients

Potential to improve patient outcomes beyond the first-year post-heart transplant

2025-04-28
(Press-News.org) 28 April, Boston—Molecular testing is transforming post-transplant care, reducing the need for invasive biopsies and personalizing medication regimens to lower the risk of infection and other downstream side effects, according to a presentation by Jeffrey Teuteberg, MD, this morning at the Annual Meeting and Scientific Sessions of the International Society of Heart and Lung Transplantation (ISHLT)

“We’ve had a bit of a cookie-cutter approach to post-operative care, managing heart transplant patients in roughly the same way,” said Dr. Teuteberg, Associate Chief of Cardiology and Section Chief of Heart Failure, Cardiac Transplant, and Mechanical Circulatory Support at Stanford Medicine. “Besides addressing issues that come up for a specific individual, there hasn’t been a lot of personalization.”

Post-transplant surveillance has traditionally included frequent biopsies of heart tissue and blood tests for the first few years following the transplant when the risk of organ rejection and infection is highest.

“Patients hate having the biopsies, but we haven’t had a good, non-invasive alternative,” Dr. Teuteberg said.

An early molecular test, gene expression profiling, made inroads by distinguishing between low- and high-risk transplant patients. Now, cell-free DNA (cf-DNA) testing, which identifies small DNA fragments in the bloodstream from a donor’s heart, can detect potential heart injury or rejection as early as a few weeks post-transplant. 

“When we started using cell-free DNA testing as early as a month post-transplant, we eliminated 95 percent of the biopsies during the first few years,” he said.

Using cell-free DNA testing to monitor patient response holds the promise of enabling physicians to reduce the dosage of immunosuppressive medicines and steroids in low-risk patients.

“Post-transplant medications keep the body from rejecting the donor heart, but they also can have deleterious health effects, including infections, impaired kidney function, and an increased risk for cancer,” he said. “Being able to decrease the dosage may benefit patients by reducing the incidence or severity of these complications.”

Molecular testing also offers the potential to:

screen patients for viruses to personalize the duration of post-transplant antivirals and antibiotics 

test the patients’ own DNA to determine levels of viruses and bacteria in the gut biome, which may correlate with their level of immunosuppression detect early cancer cells to adjust screening rates for patients at high risk study gene expression in the heart tissue removed during biopsies. Dr. Teuteberg said molecular testing is already improving access to heart transplants and quality of life for recipients.

“One of the things that disadvantages patients who need a transplant is their ability to get to a transplant center, not only for the procedure but for ongoing testing,” he said. “Being able to surveil patients remotely is more convenient for patients. I think it democratizes the heart transplant in a way that is really exciting.”

While it’s difficult to quantify, Dr. Teuteberg said better surveillance of patients over a longer period of time could impact survival and outcome rates for heart transplant recipients.

“Even if the impact is relatively modest, it would be a huge change because we haven't really been able to bend the survival curve beyond the first six months or a year despite all the great advances of the past 20 years,” he said. “If we're better at identifying who's at high risk of rejection and preventing that, it will have a huge tail in terms of the benefit over time.

“It doesn't take much of a change of the survival curve early post-transplant to have an impact on long-term survival,” Dr. Teuteberg said. 

END

About ISHLT
The International Society for Heart and Lung Transplantation (ISHLT) is a not-for-profit, multidisciplinary, professional organization dedicated to improving the care of patients with advanced heart or lung disease through transplantation, mechanical support, and innovative therapies via research, education, and advocacy. ISHLT members focus on transplantation and a range of interventions and therapies related to advanced heart and lung disease.

The ISHLT Annual Meeting and Scientific Sessions will be held from 27-30 April at the John B. Hynes Veterans Memorial Convention Center in Boston.

Contact:
Jess Burke, Director of Marketing and Communications
+1.312.224.0015
jess.burke@ishlt.org

END



ELSE PRESS RELEASES FROM THIS DATE:

Geoengineering technique could cool planet using existing aircraft

2025-04-28
A technique to cool the planet, in which particles are added to the atmosphere to reflect sunlight, would not require developing special aircraft but could be achieved using existing large planes, according to a new modelling study led by UCL (University College London) researchers. Previously, most research has assumed that the technique, known as stratospheric aerosol injection, would be deployed in the tropics and so would require specially designed aircraft capable of flying at altitudes of 20km or more to inject the particles. For the new study, published in the journal ...

‘Wood you believe it?’ FAU engineers fortify wood with eco-friendly nano-iron

2025-04-28
Scientists and engineers are developing high-performance materials from eco-friendly sources like plant waste. A key component, lignocellulose – found in wood and many plants – can be easily collected and chemically modified to improve its properties. By using these kinds of chemical changes, researchers are creating advanced materials and new ways to design and build sustainably. With about 181.5 billion tons of wood produced globally each year, it’s one of the largest renewable material sources. Researchers from the College of Engineering and Computer Science at Florida Atlantic University, and collaborators ...

Mary Ann Liebert, Inc. announces winners of RFS Awards in Science 2024

2025-04-28
Mary Ann Liebert, Inc. proudly announces the recipients of the RFS Awards in Science 2024, recognizing outstanding peer-reviewed research by women and underrepresented minorities in STEM. To view the full list of winners, click here. The RFS Awards in Science 2024 honor the best papers written in 2024 by a woman or underrepresented minority in science across Mary Ann Liebert, Inc.’s portfolio of peer-reviewed journals. The awards highlight the critical contributions of these researchers and reinforce the company’s commitment to amplifying diverse voices in scientific discovery. Each ...

Anticancer mechanisms of indigenous food plants in Nigeria

2025-04-28
Cancer is one of the leading causes of mortality worldwide, with significant impacts in Nigeria, where the incidence and mortality rates continue to rise. The prevalence of cancers such as breast, cervical, prostate, and liver cancer is high in the region. Although conventional cancer treatments like chemotherapy and radiotherapy have advanced, there remains an urgent need for safer and more effective alternatives. Indigenous food plants in Nigeria have shown promise due to their rich bioactive compounds, which ...

Research alert: High cannabis use linked to increased mortality in colon cancer patients

2025-04-28
Researchers at the University of California San Diego School of Medicine have found that individuals with colon cancer and a documented history of high cannabis use were more than 20 times more likely to die within five years of diagnosis compared to those without such a history. “This study adds to a growing body of evidence suggesting that heavy cannabis use may have underrecognized impacts on the immune system, mental health and treatment behaviors — all of which could influence cancer outcomes,” said lead author Raphael Cuomo, Ph.D., associate professor in the Department of Anesthesiology at UC San Diego School of Medicine. The research team drew ...

New study confirms beech leaf disease threatens european beech trees, too

2025-04-28
KIRTLAND, OHIO — A new study from Holden Forests & Gardens and a team at USDA Agricultural Research Service confirms that beech leaf disease—a fast-spreading disease already devastating American beech across eastern North America—also affects European beech (Fagus sylvatica). The research raises concerns that the disease could spread globally, threatening the health of forests across Europe. European beech is a cornerstone of native forests in Europe as well as a common ornamental species planted across North America. To date, beech leaf disease has not been reported in Europe.  Published in the journal Plant Pathology, the ...

Carnegie Mellon launches Human-Centered AI Research Center with Seoul National University

2025-04-28
Carnegie Mellon University and Seoul National University (SNU) have announced a new collaboration to advance human-centered artificial intelligence research that prioritizes human well-being, accessibility and social responsibility. The SNU-CMU Human-Centered AI Research Center (HCAI) aims to pioneer innovative AI solutions by combining interdisciplinary expertise in human-centered design. “We’re excited to officially launch this partnership with our colleagues at Seoul National University,” said Laura Dabbish, professor in the Human-Computer Interaction Institute at Carnegie Mellon University’s School of Computer Science. ...

Layered semiconductor shows potential for next-gen data storage

2025-04-28
PULLMAN, Wash. — A squishy, layered material that dramatically transforms under pressure could someday help computers store more data with less energy. That’s according to a new study by researchers at Washington State University and the University of North Carolina at Charlotte that shows a hybrid zinc telluride-based material can undergo surprising structural changes when squeezed together like a molecular sandwich. Those changes could make it a strong candidate for phase change memory, ...

Dual scalable annealing processors: overcoming capacity and precision limits

2025-04-28
Combinatorial optimization problems (COPs) arise in various fields such as shift scheduling, traffic routing, and drug development. However, they are challenging to solve using traditional computers in a practical timeframe. Alternatively, annealing processors (APs), which are specialized hardware for solving COPs, have gained significant attention. They are based on the Ising model, in which COP variables are presented as magnetic spins and constraints as interactions between spins. Solutions are obtained by finding the spin state that minimizes the energy of the system. There are two types of Ising models, the sparsely-coupled model and the fully-coupled model. Sparsely-coupled ...

Genetic secrets of rice pave way for future farming and conservation

2025-04-28
A new study, seen in Nature Genetics and led by researchers at King Abdullah University of Science and Technology (KAUST; Saudi Arabia) and Wageningen University & Research (the Netherlands), provides new insights on rice evolution, showing how the DNA of this valuable crop has changed across species. The findings are expected to not only help with improving rice yields but also with the introduction of rice into regions where rice production is currently untenable.   Rice is one of the first domesticated crops (approximately 10,000 years ago). The artificial selection farmers ...

LAST 30 PRESS RELEASES:

A threesome that hatches potato parasites

Young people discover the technologies shaping their future in the World Economic Forum and Frontiers for Young Minds collection

Real-time 3D visualization reveals potent antibacterial and antibiofilm activity against superbacteria

Abnormal uterine bleeding and insulin resistance are on the rise: Is there a connection?

Eye wear breakthrough: MXene-coated lenses for safer and smarter wearables

‘AI scientist’ suggests combinations of widely available non-cancer drugs can kill cancer cells

Phage therapy at a turning point: Global experts converge in Berlin to shape the future of antimicrobial medicine

Low calorie diets linked to heightened risk of depressive symptoms

Bronchiolitis, monoclonal antibody halves hospitalizations of children younger than six months old

Mum’s obesity linked to child’s heightened hospital admission risk for infection

Millions of new solar system objects to be found and ‘filmed in technicolor’ – studies predict

Pitt study has upended decades-old assumptions about brain plasticity

Hertz Foundation partners with Analog Devices to empower future leaders in analog, digital and software technology solutions

Would you hand over your health data if it meant better care?

Study examines how well wearable tech tracks fitness metrics

Dr. Nikolaos Koundouros wins 2025 Tri-Institutional Breakout Award

Low vs. High blood pressure avoidance in non-cardiac surgery: Neurocognitive outcomes unchanged

Telehealth can improve care for cats with chronic health issues

Researchers develop innovative model to study sense of smell

Birds may be drinking on the wing, but in moderation

Collaboration can unlock Australia’s energy transition without sacrificing natural capital

Study identifies proteins involved in the effectiveness of immunotherapy against blood cancer

Cannabis extract could treat fungal diseases

Pancreatic cancer spreads to liver or lung thanks to this protein

Eating an array of smaller fish could be nutrient-dense solution to overfishing

Han studying potential of next generation telepresence

Emory study finds molecular link between air pollution and pregnancy risks

Controlling bacteria with light: from tackling antibiotic resistance to “bacterial robots”

Johns Hopkins study shows how scientists can use black holes as supercolliders

Being incarcerated and living in areas where more have gone to jail is associated with higher death rates

[Press-News.org] Molecular tests provide more convenient, personalized monitoring of heart transplant recipients
Potential to improve patient outcomes beyond the first-year post-heart transplant